Quest/Unilab
This article was originally published in The Gray Sheet
Executive Summary
Quest Diagnostics will submit more information on its proposed acquisition of diagnostic testing services firm Unilab following a request from the Federal Trade Commission. Completion of the $1.1 bil. purchase, first announced April 2, is expected to be delayed until the third quarter (1"The Gray Sheet" April 8, 2002, p. 19)...
You may also be interested in...
LabCorp Enhances Cancer Testing Capability With $600 Mil. Dianon Purchase
LabCorp says it does not foresee antitrust issues with the Federal Trade Commission related to the acquisition of cancer testing firm Dianon
Quest Diagnostics Spends $1.6 Bil. To Expand Presence In California, D.C.
Quest Diagnostics will control 12% of the $3.8 bil. California lab testing market following the acquisition of Unilab Corp. The $1.1 bil. deal was announced April 2, one day after Quest completed its $500 mil. cash acquisition of Amercian Medical Labs (AML)
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”